Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection

• Ann E. Lin,

  Affiliation Division of Pediatric Pharmacology & Drug Discovery, University of California, San Diego, La Jolla, California, United States of America

  ⨯
• Federico C. Beasley,

  Affiliation Division of Pediatric Pharmacology & Drug Discovery, University of California, San Diego, La Jolla, California, United States of America

  ⨯
• Joshua Olson,

  Affiliation Division of Pediatric Pharmacology & Drug Discovery, University of California, San Diego, La Jolla, California, United States of America

  ⨯
• Nadia Keller,

  Affiliation Division of Pediatric Pharmacology & Drug Discovery, University of California, San Diego, La Jolla, California, United States of America

  ⨯
• Robert A. Shalwitz,

  Affiliation Aerpio Therapeutics, Cincinnati, Ohio, United States of America

  ⨯
• Thomas J. Hannan,

  Affiliations Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, United States of America, Center for Women’s Infectious Disease Research, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Scott J. Hultgren,

  Affiliations Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, United States of America, Center for Women’s Infectious Disease Research, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Victor Nizet

  * E-mail: vnizet@ucsd.edu

  Affiliations Division of Pediatric Pharmacology & Drug Discovery, University of California, San Diego, La Jolla, California, United States of America, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, United States of America, Rady Children’s Hospital, San Diego, California, United States of America

  ⨯